Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | TYMP | P19971 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.46 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.46 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.46 |
| ▸ | GAPDH | P04406 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.46 |
| ▸ | STAT6 | P42226 | 1/20 | 0.46 |
| ▸ | PI4KA | P42356 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24538657 | 1.00 | SLC29A1 (0.55) | SLC29A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL3168059 | 0.87 | EGFR (0.45) | SLC29A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL19344399 | 0.87 | TYMP (0.45) | SLC29A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL3168049 | 0.87 | EGFR (0.45) | SLC29A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL12386194 | 0.87 | TYMP (0.45) | SLC29A1PDE4APDE4BPDE4CPDE4D | |
| SCHEMBL98801 | 0.86 | SLC29A1 (0.56) | SLC29A1ADORA3DPP4MEN1SLC28A1 | |
| SCHEMBL98800 | 0.86 | SLC29A1 (0.56) | SLC29A1ADORA3DPP4MEN1SLC28A1 | |
| Cordycepin SCHEMBL21562220 | 0.85 | ADORA3 (0.63) | SLC29A1ADORA3DPP4MEN1SLC28A1 | |
| Cordycepin SCHEMBL23735980 | 0.85 | ADORA3 (0.63) | SLC29A1ADORA3DPP4MEN1SLC28A1 | |
| Cordycepin SCHEMBL21591024 | 0.85 | ADORA3 (0.63) | SLC29A1ADORA3DPP4MEN1SLC28A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030204080-A1 | Methods for producing nucleoside derivatives and intermediates therefor | AJINOMOTO CO. INC (JP) | 2003-10-30 | — | — | US | disclosed |
| US-20030004330-A1 | Methods for producing nucleoside derivatives and intermediates therefor | AJINOMOTO CO. INC (JP) | 2003-01-02 | — | — | US | disclosed |
| US-6500946-B1 | LOW COST, SIMPLE, HIGH YIELD PRODUCTION, INCLUDING THAT OF ANTIVIRAL AGENT 9-(2,3-DIDEOXY-2-FLUORO-.BETA.-D-THREO-PENTOFURANOSYL)ADENINE (FDDA) | AJINOMOTO CO., INC. (JP) | 2002-12-31 | — | — | US | disclosed |
| US-6090937-A | Methods for producing nucleoside derivatives and intermediates therefor | AJINOMOTO CO., INC. (JP) | 2000-07-18 | — | — | US | disclosed |
| EP-0945460-A1 | Methods for producing nucleoside derivatives and intermediates therefore | Ajinomoto Co., Inc. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004330-A1 | Methods for producing nucleoside derivatives and intermediates therefor | DCTD, ADAR, IMPDH1 | SLC29A1 26/4885PDE4A 1063/4885PDE4B 656/4885 |
| US-20030204080-A1 | Methods for producing nucleoside derivatives and intermediates therefor | DCTD, ADAR, IMPDH1 | SLC29A1 26/4885PDE4A 1063/4885PDE4B 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.